Briefs: Lupin and Alembic

Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.

Dr. Lal PathLabs selects Kyndryl for cloud services management

Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces

Precision appoints John Hubbard, PhD, as Board of Directors Chair

Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.

Agilent announces digital pathology workflow solution

Open, scalable, end-to-end solution to improve diagnostic quality and efficiency

Marksans Pharma announces USFDA approval for Famotidine Tablets

Marksans' OTC Famotidine Tablets USP are acid reducers

USFDA completes inspection of Lupin’s Vizag facility

The inspection concluded with no observations

Alembic receives USFDA tentative approval for Brexpiprazole Tablets

Clariant launches Plantasens Pro LM

Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Resomer used in commercial 3D-printed implants for both soft and hard tissue applications

Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)